Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

EDWARDS LIFESCIENCES CORPORATION

(EW)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 10/22 12:08:42 pm
116.155 USD   +0.36%
10/20EDWARDS LIFESCIENCES : To Host Earnings Conference Call On October 27, 2021
PR
10/18INSIDER SELL : Edwards Lifesciences
MT
10/11INSIDER SELL : Edwards Lifesciences
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/18/2021 10/19/2021 10/20/2021 10/21/2021 10/22/2021 Date
111.09(c) 115(c) 115.6(c) 115.74(c) 115.94 Last
1 814 210 2 154 344 2 026 786 1 764 555 563 581 Volume
-0.95% +3.52% +0.52% +0.12% +0.17% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 5 331 M - -
Net income 2021 1 422 M - -
Net cash position 2021 1 403 M - -
P/E ratio 2021 50,4x
Yield 2021 -
Sales 2022 5 891 M - -
Net income 2022 1 511 M - -
Net cash position 2022 2 382 M - -
P/E ratio 2022 47,2x
Yield 2022 -
Capitalization 72 144 M 72 144 M -
EV / Sales 2021 13,3x
EV / Sales 2022 11,8x
Nbr of Employees 14 900
Free-Float 96,6%
More Financials
Company
Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products and technologies are categorized into four main areas:... 
More about the company
Ratings of Edwards Lifesciences Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about EDWARDS LIFESCIENCES CORPORATION
10/20EDWARDS LIFESCIENCES : To Host Earnings Conference Call On October 27, 2021
PR
10/18INSIDER SELL : Edwards Lifesciences
MT
10/11INSIDER SELL : Edwards Lifesciences
MT
10/04Edwards Lifesciences on Pace for Largest Percent Decrease Since October 2020 -- Data Ta..
DJ
10/04INSIDER SELL : Edwards Lifesciences
MT
09/16INSIDER SELL : Edwards Lifesciences
MT
09/13INSIDER SELL : Edwards Lifesciences
MT
09/09INSIDER SELL : Edwards Lifesciences
MT
09/05HOUSTON WE HAVE : Edwards Lifesciences to Fund Houston We Have's Clinical Trial of ECHOiQ'..
MT
08/03EDWARDS LIFESCIENCES : Goldman Sachs Adjusts Edwards Lifesciences' Price Target to $105 fr..
MT
08/02EDWARDS LIFESCIENCES : Raymond James Adjusts Edwards Lifesciences' Price Target to $122 fr..
MT
08/02EDWARDS LIFESCIENCES : initiates $100 million social impact investment fund to advance rac..
PU
07/30EDWARDS LIFESCIENCES : Management's Discussion and Analysis of Financial Condition and Res..
AQ
07/30TRANCHE UPDATE ON EDWARDS LIFESCIENC : EW)'s Equity Buyback Plan announced on May 5, 2021.
CI
07/30TRANCHE UPDATE ON EDWARDS LIFESCIENC : EW)'s Equity Buyback Plan announced on May 8, 2019.
CI
More news
News in other languages on EDWARDS LIFESCIENCES CORPORATION
09/16VENTE PAR DES INITIÉS : Edwards Lifesciences
2019Les valeurs à suivre à Wall Street
2017Les valeurs à suivre à Wall Street
2017Les valeurs à suivre à Wall Street
2017Wall Street se replie légèrement, Trump ne surprend pas sur la fiscalité
More news
Analyst Recommendations on EDWARDS LIFESCIENCES CORPORATION
More recommendations
Chart EDWARDS LIFESCIENCES CORPORATION
Duration : Period :
Edwards Lifesciences Corporation Technical Analysis Chart | EW | US28176E1082 | MarketScreener
Technical analysis trends EDWARDS LIFESCIENCES CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Last Close Price 115,74 $
Average target price 117,65 $
Spread / Average Target 1,65%
EPS Revisions
Managers and Directors
Michael A. Mussallem Chairman & Chief Executive Officer
Scott B. Ullem Chief Financial Officer & Vice President
Todd J. Brinton Chief Scientific Officer & VP-Advanced Technology
Nicholas J. Valeriani Independent Director
Kieran Thomas Gallahue Independent Director
Sector and Competitors